Optic Neuritis – Pipeline Review, H1 2016 – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Optic Neuritis - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic development for Optic Neuritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews
